Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
Open Access
- 1 January 2012
- journal article
- Published by The Korean Association for the Study of the Liver in Clinical and Molecular Hepatology
- Vol. 18 (4), 383-390
- https://doi.org/10.3350/cmh.2012.18.4.383
Abstract
Serum bilirubin exerts antioxidant and cytoprotective effects. In addition, elevated serum bilirubin levels are associated with a decreased risk of metabolic and cardiovascular diseases. However, few studies have evaluated whether serum bilirubin is associated with non-alcoholic fatty liver disease (NAFLD), which is closely associated with other metabolic diseases. The aim of this study was thus to elucidate the association between serum total bilirubin levels and NAFLD. A cross-sectional study of 17,348 subjects undergoing a routine health check-up was conducted. Subjects positive for hepatitis B or hepatitis C virus, or with other hepatitis history were excluded. NAFLD was diagnosed on the basis of typical ultrasonographic findings and an alcohol consumption of less than 20 g/day. The mean age of the subjects was 49 years and 9,076 (52.3%) were men. The prevalence of NAFLD decreased steadily as the serum bilirubin level increased in both men and women (P<0.001 for both). Multivariate regression analysis adjusted for other metabolic risk factors showed that serum bilirubin level was inversely associated with the prevalence of NAFLD [odds ratio (OR)=0.88, 95% confidence interval (CI)=0.80-0.97]. Furthermore, there was an inverse, dose-dependent association between NAFLD and serum total bilirubin levels (OR=0.83, 95% CI=0.75-0.93 in the third quartile; OR=0.80, 95% CI=0.71-0.90 in the fourth quartile vs. lowest quartile, P for trend <0.001). Serum bilirubin levels were found to be inversely associated with the prevalence of NAFLD independent of known metabolic risk factors. Serum bilirubin might be a protective marker for NAFLD.Keywords
This publication has 35 references indexed in Scilit:
- A Cohort Study of Serum Bilirubin Levels and Incident Non-Alcoholic Fatty Liver Disease in Middle Aged Korean WorkersPLOS ONE, 2012
- The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular DiseasesFrontiers in Pharmacology, 2012
- Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart studyHepatology, 2010
- High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006Journal of Clinical Medicine Research, 2010
- Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescentsAtherosclerosis, 2009
- Serum Total Bilirubin Level, Prevalent Stroke, and Stroke Outcomes: NHANES 1999–2004American Journal Of Medicine, 2008
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levelsAtherosclerosis, 2002
- Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Damage to biological tissues induced by radical initiator 2,2′-azobis(2-amidinopropane) dihydrochloride and its inhibition by chain-breaking antioxidantsJournal of Free Radicals in Biology & Medicine, 1986